Drug Shortage Report for JAMP-SOLIFENACIN

Last updated on 2024-04-17 History
Report ID 162505
Drug Identification Number 02424347
Brand name JAMP-SOLIFENACIN
Common or Proper name Solifenacin Succinate Tablets
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) SOLIFENACIN SUCCINATE
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30 (bottle)
ATC code G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-05-31
Estimated end date 2024-01-31
Actual end date 2024-04-15
Shortage status Resolved
Updated date 2024-04-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2024-04-17 French Compare
v15 2024-04-17 English Compare
v14 2023-09-26 French Compare
v13 2023-09-26 English Compare
v12 2022-12-09 French Compare
v11 2022-12-09 English Compare
v10 2022-11-09 French Compare
v9 2022-11-09 English Compare
v8 2022-10-07 French Compare
v7 2022-10-07 English Compare
v6 2022-09-19 French Compare
v5 2022-09-19 English Compare
v4 2022-09-16 French Compare
v3 2022-09-16 English Compare
v2 2022-06-13 French Compare
v1 2022-06-13 English Compare

Showing 1 to 16 of 16